Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113256
Status:
TERMINATED
Last Update Posted:
2013-01-23
First Post:
2005-06-06
Brief Title:
Orathecin Gemcitabine Versus Placebo Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
Sponsor:
Astex Pharmaceuticals Inc
Organization:
Astex Pharmaceuticals Inc
Organization Data
Organization:
Astex Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
SGI-RUB-048
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Astex Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None